Global Anti-HER2 Therapy Market Research Report 2024, Forecast to 2032

October 2024 | 142 pages | ID: GF91BEBD18A5EN
Bosson Research

Abstracts

Report Overview

Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-positive breast cancer, the HER2 (human epidermal growth factor receptor 2) gene doesn’t work correctly and makes too many copies of itself. These extra HER2 genes make too many proteins known as HER2 receptors.Anti-HER2 medicines attach to the HER2 receptor proteins on the surface of breast cancer cells.Anti-HER2 medicines work by blocking the HER2 receptors from receiving the growth signals in HER2-positive breast cancer. By blocking the growth signals, anti-HER2 medicines can slow or stop the growth of HER2-positive and HER2-low breast cancer. Anti-HER2 medicines only work on HER2-positive and HER2-low breast cancer. They do not work on HER2-negative breast cancer.

The global Anti-HER2 Therapy market size was estimated at USD 5690 million in 2023 and is projected to reach USD 8455.88 million by 2032, exhibiting a CAGR of 4.50% during the forecast period.

North America Anti-HER2 Therapy market size was estimated at USD 1599.23 million in 2023, at a CAGR of 3.86% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Anti-HER2 Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-HER2 Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-HER2 Therapy market in any manner.

Global Anti-HER2 Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GlaxoSmithKline

Bayer

Abbott

AbbVie

Pfizer

Sanofi

Merck

Glenmark Pharmaceuticals

Roche

Novartis

Astra Zeneca

Daiichi Sankyo

Celltrion

Teva

Biocon

Viatris

Market Segmentation (by Type)

Anti-HER2 Monoclonal Antibodies

Antibody-Drug Conjugate

Kinase Inhibitors

Market Segmentation (by Application)

Online Pharmacy

Retail Pharmacy

Medical Clinics

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Anti-HER2 Therapy Market
• Overview of the regional outlook of the Anti-HER2 Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-HER2 Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Anti-HER2 Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Anti-HER2 Therapy
1.2 Key Market Segments
  1.2.1 Anti-HER2 Therapy Segment by Type
  1.2.2 Anti-HER2 Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ANTI-HER2 THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Anti-HER2 Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global Anti-HER2 Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ANTI-HER2 THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Global Anti-HER2 Therapy Sales by Manufacturers (2019-2024)
3.2 Global Anti-HER2 Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-HER2 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-HER2 Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-HER2 Therapy Sales Sites, Area Served, Product Type
3.6 Anti-HER2 Therapy Market Competitive Situation and Trends
  3.6.1 Anti-HER2 Therapy Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Anti-HER2 Therapy Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 ANTI-HER2 THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Anti-HER2 Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ANTI-HER2 THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 ANTI-HER2 THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-HER2 Therapy Sales Market Share by Type (2019-2024)
6.3 Global Anti-HER2 Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Anti-HER2 Therapy Price by Type (2019-2024)

7 ANTI-HER2 THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-HER2 Therapy Market Sales by Application (2019-2024)
7.3 Global Anti-HER2 Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-HER2 Therapy Sales Growth Rate by Application (2019-2024)

8 ANTI-HER2 THERAPY MARKET CONSUMPTION BY REGION

8.1 Global Anti-HER2 Therapy Sales by Region
  8.1.1 Global Anti-HER2 Therapy Sales by Region
  8.1.2 Global Anti-HER2 Therapy Sales Market Share by Region
8.2 North America
  8.2.1 North America Anti-HER2 Therapy Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Anti-HER2 Therapy Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Anti-HER2 Therapy Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Anti-HER2 Therapy Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Anti-HER2 Therapy Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 ANTI-HER2 THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of Anti-HER2 Therapy by Region (2019-2024)
9.2 Global Anti-HER2 Therapy Revenue Market Share by Region (2019-2024)
9.3 Global Anti-HER2 Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-HER2 Therapy Production
  9.4.1 North America Anti-HER2 Therapy Production Growth Rate (2019-2024)
  9.4.2 North America Anti-HER2 Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-HER2 Therapy Production
  9.5.1 Europe Anti-HER2 Therapy Production Growth Rate (2019-2024)
  9.5.2 Europe Anti-HER2 Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-HER2 Therapy Production (2019-2024)
  9.6.1 Japan Anti-HER2 Therapy Production Growth Rate (2019-2024)
  9.6.2 Japan Anti-HER2 Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-HER2 Therapy Production (2019-2024)
  9.7.1 China Anti-HER2 Therapy Production Growth Rate (2019-2024)
  9.7.2 China Anti-HER2 Therapy Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 GlaxoSmithKline
  10.1.1 GlaxoSmithKline Anti-HER2 Therapy Basic Information
  10.1.2 GlaxoSmithKline Anti-HER2 Therapy Product Overview
  10.1.3 GlaxoSmithKline Anti-HER2 Therapy Product Market Performance
  10.1.4 GlaxoSmithKline Business Overview
  10.1.5 GlaxoSmithKline Anti-HER2 Therapy SWOT Analysis
  10.1.6 GlaxoSmithKline Recent Developments
10.2 Bayer
  10.2.1 Bayer Anti-HER2 Therapy Basic Information
  10.2.2 Bayer Anti-HER2 Therapy Product Overview
  10.2.3 Bayer Anti-HER2 Therapy Product Market Performance
  10.2.4 Bayer Business Overview
  10.2.5 Bayer Anti-HER2 Therapy SWOT Analysis
  10.2.6 Bayer Recent Developments
10.3 Abbott
  10.3.1 Abbott Anti-HER2 Therapy Basic Information
  10.3.2 Abbott Anti-HER2 Therapy Product Overview
  10.3.3 Abbott Anti-HER2 Therapy Product Market Performance
  10.3.4 Abbott Anti-HER2 Therapy SWOT Analysis
  10.3.5 Abbott Business Overview
  10.3.6 Abbott Recent Developments
10.4 AbbVie
  10.4.1 AbbVie Anti-HER2 Therapy Basic Information
  10.4.2 AbbVie Anti-HER2 Therapy Product Overview
  10.4.3 AbbVie Anti-HER2 Therapy Product Market Performance
  10.4.4 AbbVie Business Overview
  10.4.5 AbbVie Recent Developments
10.5 Pfizer
  10.5.1 Pfizer Anti-HER2 Therapy Basic Information
  10.5.2 Pfizer Anti-HER2 Therapy Product Overview
  10.5.3 Pfizer Anti-HER2 Therapy Product Market Performance
  10.5.4 Pfizer Business Overview
  10.5.5 Pfizer Recent Developments
10.6 Sanofi
  10.6.1 Sanofi Anti-HER2 Therapy Basic Information
  10.6.2 Sanofi Anti-HER2 Therapy Product Overview
  10.6.3 Sanofi Anti-HER2 Therapy Product Market Performance
  10.6.4 Sanofi Business Overview
  10.6.5 Sanofi Recent Developments
10.7 Merck
  10.7.1 Merck Anti-HER2 Therapy Basic Information
  10.7.2 Merck Anti-HER2 Therapy Product Overview
  10.7.3 Merck Anti-HER2 Therapy Product Market Performance
  10.7.4 Merck Business Overview
  10.7.5 Merck Recent Developments
10.8 Glenmark Pharmaceuticals
  10.8.1 Glenmark Pharmaceuticals Anti-HER2 Therapy Basic Information
  10.8.2 Glenmark Pharmaceuticals Anti-HER2 Therapy Product Overview
  10.8.3 Glenmark Pharmaceuticals Anti-HER2 Therapy Product Market Performance
  10.8.4 Glenmark Pharmaceuticals Business Overview
  10.8.5 Glenmark Pharmaceuticals Recent Developments
10.9 Roche
  10.9.1 Roche Anti-HER2 Therapy Basic Information
  10.9.2 Roche Anti-HER2 Therapy Product Overview
  10.9.3 Roche Anti-HER2 Therapy Product Market Performance
  10.9.4 Roche Business Overview
  10.9.5 Roche Recent Developments
10.10 Novartis
  10.10.1 Novartis Anti-HER2 Therapy Basic Information
  10.10.2 Novartis Anti-HER2 Therapy Product Overview
  10.10.3 Novartis Anti-HER2 Therapy Product Market Performance
  10.10.4 Novartis Business Overview
  10.10.5 Novartis Recent Developments
10.11 Astra Zeneca
  10.11.1 Astra Zeneca Anti-HER2 Therapy Basic Information
  10.11.2 Astra Zeneca Anti-HER2 Therapy Product Overview
  10.11.3 Astra Zeneca Anti-HER2 Therapy Product Market Performance
  10.11.4 Astra Zeneca Business Overview
  10.11.5 Astra Zeneca Recent Developments
10.12 Daiichi Sankyo
  10.12.1 Daiichi Sankyo Anti-HER2 Therapy Basic Information
  10.12.2 Daiichi Sankyo Anti-HER2 Therapy Product Overview
  10.12.3 Daiichi Sankyo Anti-HER2 Therapy Product Market Performance
  10.12.4 Daiichi Sankyo Business Overview
  10.12.5 Daiichi Sankyo Recent Developments
10.13 Celltrion
  10.13.1 Celltrion Anti-HER2 Therapy Basic Information
  10.13.2 Celltrion Anti-HER2 Therapy Product Overview
  10.13.3 Celltrion Anti-HER2 Therapy Product Market Performance
  10.13.4 Celltrion Business Overview
  10.13.5 Celltrion Recent Developments
10.14 Teva
  10.14.1 Teva Anti-HER2 Therapy Basic Information
  10.14.2 Teva Anti-HER2 Therapy Product Overview
  10.14.3 Teva Anti-HER2 Therapy Product Market Performance
  10.14.4 Teva Business Overview
  10.14.5 Teva Recent Developments
10.15 Biocon
  10.15.1 Biocon Anti-HER2 Therapy Basic Information
  10.15.2 Biocon Anti-HER2 Therapy Product Overview
  10.15.3 Biocon Anti-HER2 Therapy Product Market Performance
  10.15.4 Biocon Business Overview
  10.15.5 Biocon Recent Developments
10.16 Viatris
  10.16.1 Viatris Anti-HER2 Therapy Basic Information
  10.16.2 Viatris Anti-HER2 Therapy Product Overview
  10.16.3 Viatris Anti-HER2 Therapy Product Market Performance
  10.16.4 Viatris Business Overview
  10.16.5 Viatris Recent Developments

11 ANTI-HER2 THERAPY MARKET FORECAST BY REGION

11.1 Global Anti-HER2 Therapy Market Size Forecast
11.2 Global Anti-HER2 Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Anti-HER2 Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific Anti-HER2 Therapy Market Size Forecast by Region
  11.2.4 South America Anti-HER2 Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of Anti-HER2 Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global Anti-HER2 Therapy Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of Anti-HER2 Therapy by Type (2025-2032)
  12.1.2 Global Anti-HER2 Therapy Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of Anti-HER2 Therapy by Type (2025-2032)
12.2 Global Anti-HER2 Therapy Market Forecast by Application (2025-2032)
  12.2.1 Global Anti-HER2 Therapy Sales (K Units) Forecast by Application
  12.2.2 Global Anti-HER2 Therapy Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-HER2 Therapy Market Size Comparison by Region (M USD)
Table 5. Global Anti-HER2 Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Anti-HER2 Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-HER2 Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-HER2 Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-HER2 Therapy as of 2022)
Table 10. Global Market Anti-HER2 Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-HER2 Therapy Sales Sites and Area Served
Table 12. Manufacturers Anti-HER2 Therapy Product Type
Table 13. Global Anti-HER2 Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-HER2 Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-HER2 Therapy Market Challenges
Table 22. Global Anti-HER2 Therapy Sales by Type (K Units)
Table 23. Global Anti-HER2 Therapy Market Size by Type (M USD)
Table 24. Global Anti-HER2 Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Anti-HER2 Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Anti-HER2 Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-HER2 Therapy Market Size Share by Type (2019-2024)
Table 28. Global Anti-HER2 Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Anti-HER2 Therapy Sales (K Units) by Application
Table 30. Global Anti-HER2 Therapy Market Size by Application
Table 31. Global Anti-HER2 Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Anti-HER2 Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Anti-HER2 Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-HER2 Therapy Market Share by Application (2019-2024)
Table 35. Global Anti-HER2 Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-HER2 Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Anti-HER2 Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Anti-HER2 Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Anti-HER2 Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Anti-HER2 Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Anti-HER2 Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Anti-HER2 Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global Anti-HER2 Therapy Production (K Units) by Region (2019-2024)
Table 44. Global Anti-HER2 Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-HER2 Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-HER2 Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Anti-HER2 Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Anti-HER2 Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Anti-HER2 Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Anti-HER2 Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. GlaxoSmithKline Anti-HER2 Therapy Basic Information
Table 52. GlaxoSmithKline Anti-HER2 Therapy Product Overview
Table 53. GlaxoSmithKline Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Anti-HER2 Therapy SWOT Analysis
Table 56. GlaxoSmithKline Recent Developments
Table 57. Bayer Anti-HER2 Therapy Basic Information
Table 58. Bayer Anti-HER2 Therapy Product Overview
Table 59. Bayer Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Bayer Business Overview
Table 61. Bayer Anti-HER2 Therapy SWOT Analysis
Table 62. Bayer Recent Developments
Table 63. Abbott Anti-HER2 Therapy Basic Information
Table 64. Abbott Anti-HER2 Therapy Product Overview
Table 65. Abbott Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Abbott Anti-HER2 Therapy SWOT Analysis
Table 67. Abbott Business Overview
Table 68. Abbott Recent Developments
Table 69. AbbVie Anti-HER2 Therapy Basic Information
Table 70. AbbVie Anti-HER2 Therapy Product Overview
Table 71. AbbVie Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. AbbVie Business Overview
Table 73. AbbVie Recent Developments
Table 74. Pfizer Anti-HER2 Therapy Basic Information
Table 75. Pfizer Anti-HER2 Therapy Product Overview
Table 76. Pfizer Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Pfizer Business Overview
Table 78. Pfizer Recent Developments
Table 79. Sanofi Anti-HER2 Therapy Basic Information
Table 80. Sanofi Anti-HER2 Therapy Product Overview
Table 81. Sanofi Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Merck Anti-HER2 Therapy Basic Information
Table 85. Merck Anti-HER2 Therapy Product Overview
Table 86. Merck Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Merck Business Overview
Table 88. Merck Recent Developments
Table 89. Glenmark Pharmaceuticals Anti-HER2 Therapy Basic Information
Table 90. Glenmark Pharmaceuticals Anti-HER2 Therapy Product Overview
Table 91. Glenmark Pharmaceuticals Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Glenmark Pharmaceuticals Business Overview
Table 93. Glenmark Pharmaceuticals Recent Developments
Table 94. Roche Anti-HER2 Therapy Basic Information
Table 95. Roche Anti-HER2 Therapy Product Overview
Table 96. Roche Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Roche Business Overview
Table 98. Roche Recent Developments
Table 99. Novartis Anti-HER2 Therapy Basic Information
Table 100. Novartis Anti-HER2 Therapy Product Overview
Table 101. Novartis Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Novartis Business Overview
Table 103. Novartis Recent Developments
Table 104. Astra Zeneca Anti-HER2 Therapy Basic Information
Table 105. Astra Zeneca Anti-HER2 Therapy Product Overview
Table 106. Astra Zeneca Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Astra Zeneca Business Overview
Table 108. Astra Zeneca Recent Developments
Table 109. Daiichi Sankyo Anti-HER2 Therapy Basic Information
Table 110. Daiichi Sankyo Anti-HER2 Therapy Product Overview
Table 111. Daiichi Sankyo Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Daiichi Sankyo Business Overview
Table 113. Daiichi Sankyo Recent Developments
Table 114. Celltrion Anti-HER2 Therapy Basic Information
Table 115. Celltrion Anti-HER2 Therapy Product Overview
Table 116. Celltrion Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Celltrion Business Overview
Table 118. Celltrion Recent Developments
Table 119. Teva Anti-HER2 Therapy Basic Information
Table 120. Teva Anti-HER2 Therapy Product Overview
Table 121. Teva Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Teva Business Overview
Table 123. Teva Recent Developments
Table 124. Biocon Anti-HER2 Therapy Basic Information
Table 125. Biocon Anti-HER2 Therapy Product Overview
Table 126. Biocon Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Biocon Business Overview
Table 128. Biocon Recent Developments
Table 129. Viatris Anti-HER2 Therapy Basic Information
Table 130. Viatris Anti-HER2 Therapy Product Overview
Table 131. Viatris Anti-HER2 Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Viatris Business Overview
Table 133. Viatris Recent Developments
Table 134. Global Anti-HER2 Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 135. Global Anti-HER2 Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Anti-HER2 Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 137. North America Anti-HER2 Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Anti-HER2 Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 139. Europe Anti-HER2 Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Anti-HER2 Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 141. Asia Pacific Anti-HER2 Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Anti-HER2 Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 143. South America Anti-HER2 Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Anti-HER2 Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Anti-HER2 Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Anti-HER2 Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 147. Global Anti-HER2 Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Anti-HER2 Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 149. Global Anti-HER2 Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 150. Global Anti-HER2 Therapy Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Anti-HER2 Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-HER2 Therapy Market Size (M USD), 2019-2032
Figure 5. Global Anti-HER2 Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Anti-HER2 Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-HER2 Therapy Market Size by Country (M USD)
Figure 11. Anti-HER2 Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Anti-HER2 Therapy Revenue Share by Manufacturers in 2023
Figure 13. Anti-HER2 Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-HER2 Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-HER2 Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-HER2 Therapy Market Share by Type
Figure 18. Sales Market Share of Anti-HER2 Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Anti-HER2 Therapy by Type in 2023
Figure 20. Market Size Share of Anti-HER2 Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-HER2 Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-HER2 Therapy Market Share by Application
Figure 24. Global Anti-HER2 Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-HER2 Therapy Sales Market Share by Application in 2023
Figure 26. Global Anti-HER2 Therapy Market Share by Application (2019-2024)
Figure 27. Global Anti-HER2 Therapy Market Share by Application in 2023
Figure 28. Global Anti-HER2 Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-HER2 Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Anti-HER2 Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Anti-HER2 Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-HER2 Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Anti-HER2 Therapy Sales Market Share by Country in 2023
Figure 37. Germany Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Anti-HER2 Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Anti-HER2 Therapy Sales Market Share by Region in 2023
Figure 44. China Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Anti-HER2 Therapy Sales and Growth Rate (K Units)
Figure 50. South America Anti-HER2 Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Anti-HER2 Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Anti-HER2 Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Anti-HER2 Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Anti-HER2 Therapy Production Market Share by Region (2019-2024)
Figure 62. North America Anti-HER2 Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Anti-HER2 Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Anti-HER2 Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China Anti-HER2 Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Anti-HER2 Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Anti-HER2 Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-HER2 Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-HER2 Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-HER2 Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-HER2 Therapy Market Share Forecast by Application (2025-2032)